ArticleBMC gastroenterology2025
Comparison of sociodemographic factors, lifestyle, and gastrointestinal symptoms between patients with endometriosis and IBS.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesEndometriosis and Irritable bowel syndrome (IBS) are two common diseases with overlapping symptomatology, causing confusion and delay in the diagnostic process. The objective of this study was to identify differences between endometriosis and IBS diagnosed according to Rome IV, by comparing sociodemographic factors, lifestyle habits, and gastrointestinal symptoms. MATERIALS AND
methodsPatients with endometriosis (n = 214), confirmed by laparoscopy or at transvaginal ultrasound, were recruited at the Department of Gynecology, Skåne University Hospital, Malmö. Patients with IBS (n = 199) were recruited from primary care centers, the Department of Gastroenterology, Skåne University Hospital, Malmö, and by advertisements at social media. All study participants answered questionnaires regarding sociodemographic factors, lifestyle habits, and medical history. Gastrointestinal symptoms were evaluated using the validated Visual Analog Scale for Irritable Bowel Syndrome (VAS-IBS).
resultsThere were limited differences in sociodemographic factors and lifestyle habits between women with endometriosis and IBS. However, endometriosis patients mainly needed analgetic treatment, opioids in 9.3% of cases, whereas IBS patients often needed drugs for intestinal dysfunction. GI symptoms were more aggravated in IBS than in endometriosis, especially diarrhea and constipation. The initial trigger events differed between the two diseases: menarche being most common in endometriosis and stress or infection/antibiotic treatment being most common in IBS. Both groups reported improvement of GI symptoms after dietary changes.
conclusionsThe findings indicate that a thorough anamnesis about onset of disease and medication needs together with rating of gastrointestinal symptoms by validated instruments could be useful tools to differentiate between endometriosis and IBS in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.